drugset / Trial / NCT07248540

IV Magnesium in the Treatment of Acute Dysmenorrhea

NCT07248540

Recruiting 60 enrolled Havva Betül Bacak
RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective, randomized, double-blind clinical trial aims to evaluate the analgesic efficacy of intravenous magnesium sulfate in women presenting to the emergency department with acute dysmenorrhea. Participants will be randomized into two groups receiving either 2 ampoules of magnesium sulfate or intravenous dexketoprofen. Pain levels will be assessed using the Visual Analog Scale (VAS) before and after treatment.

Timeline

Start
2025-07-01
Primary completion
2026-01-01
Completion
2026-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexketoprofen Small molecule 50 mg Intravenous
Subject Magnesium Sulfate Other / unclassified 8 ml Intravenous

Indications